Prescient Therapeutics Ltd has released a press release.
March 2016 Appendix 4C - Quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- Executive Management Change
- Virax Rights Offer Documentation - 25 May 2011
- VIR201 HIV Vaccine published in AIDS Journal
- Update on VIR201 HIV Vaccine Clinical Trial
- Terms Sheet - Skin Cancer
Later from Prescient Therapeutics
- PTX Secures $7.0M Capital Raising
- Offer Document
- Replacement Entitlement Offer Prospectus
- Yale Joins PTXs Phase 1b/2 AML Clinical Trial
- June 2016 Appendix 4C - Quarterly
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics